WallStSmart
NTHI

NeOnc Technologies Holdings, Inc. Common Stock

NASDAQ: NTHI · HEALTHCARE · BIOTECHNOLOGY

$5.51
-3.18% today

Updated 2026-06-05

Market cap
$114.98M
P/E ratio
P/S ratio
3,477.63x
EPS (TTM)
$-1.80
Dividend yield
52W range
$3 – $13
Volume
0.1M

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20212022202320242025
Total assets$32491.00$728682.00$1.27M$3.42M$2.82M
Cash & equivalents$25034.00$633298.00$31862.00$64893.00$58729.00
Current assets$32491.00$728682.00$1.27M$2.20M$1.39M
Total liabilities$2.65M$2.30M$15.25M$8.92M$20.33M
Current liabilities$2.65M$2.30M$15.25M$8.92M$20.04M
Long-term debt
Shareholder equity$-2.62M$-1.58M$-13.99M$-5.50M$-17.51M
Retained earnings$-20.74M$-23.79M$-38.71M$-50.61M$-112.75M
Accounts receivable$148705.00
Inventory
Goodwill

Frequently asked questions

How profitable is NTHI?

In its most recent fiscal year, NTHI ran a gross margin of 100.00%, an operating margin of -145,459.36%, and a net margin of -155,404.38%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NTHI generate?

NTHI produced $-20.86M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NTHI's balance sheet healthy?

NTHI holds $58729.00 in cash and equivalents against — in long-term debt, on $-17.51M of shareholder equity. That debt is best read against the cash flow the business throws off each year.